{"id":"NCT00601250","sponsor":"Boehringer Ingelheim","briefTitle":"Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes","officialTitle":"A Randomised, Double-blind, Placebo-controlled Parallel Group Efficacy and Safety Study of BI 1356 (One Dose, e.g. 5 mg), Administered Orally Once Daily Over 24 Weeks, With an Open Label Extension to 80 Weeks (Placebo Patients Switched to BI 1356), in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite Metformin Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-01","primaryCompletion":"2009-05","completion":null,"firstPosted":"2008-01-28","resultsPosted":"2011-06-07","lastUpdate":"2014-01-28"},"enrollment":701,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"linagliptin","otherNames":[]},{"type":"DRUG","name":"linagliptin","otherNames":[]}],"arms":[{"label":"Linagliptin","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of the current study is to investigate the efficacy, safety and tolerability of BI 1356 (5 mg once daily) compared to placebo given for 24 weeks as add-on therapy to metformin in patients with type 2 diabetes mellitus with insufficient glycaemic control","primaryOutcome":{"measure":"HbA1c Change From Baseline at Week 24","timeFrame":"Baseline and week 24","effectByArm":[{"arm":"Placebo","deltaMin":0.15,"sd":0.06},{"arm":"Linagliptin","deltaMin":-0.49,"sd":0.04}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":82,"countries":["United States","Czechia","Finland","Greece","India","Israel","Mexico","New Zealand","Russia","Sweden"]},"refs":{"pmids":["27484756"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":177},"commonTop":["Hyperglycaemia","Nasopharyngitis"]}}